Inactive Instrument

Press Releases VIVUS, Inc.

Stocks

VVUSQ

US9285513084

Pharmaceuticals

Press Releases

14/20/14	VIVUS : Receives Court Approval of Joint Chapter 11 Plan of Reorganization	AQ
16/20/16	VIVUS : Seeks Bankruptcy Court Approval of Second Amended Joint Chapter 11 Plan of Reorganization and Existing Stock Record Date	AQ
16/20/16	VIVUS INC : Other Events, Financial Statements and Exhibits (form 8-K)	AQ
13/20/13	VIVUS INC : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure (form 8-K)	AQ
08/20/08	VIVUS INC : Entry into a Material Definitive Agreement, Bankruptcy or Receivership, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
08/20/08	VIVUS Completes Solicitation for In-Court Reorganization Plan to Become a Wholly Owned Subsidiary of IEH Biopharma LLC	GL
19/20/19	VIVUS INC : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
02/20/02	VIVUS INC : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
02/20/02	VIVUS Announces Updated Agreement with Icahn Enterprises Holdings L.P.	GL
07/20/07	Vivus: 1Q Earnings Snapshot	AQ
07/20/07	VIVUS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ
07/20/07	VIVUS Reports First Quarter 2020 Financial Results	GL
04/20/04	VIVUS : to Host First Quarter Business Update and Financial Results Conference Call on Wednesday, May 6, 2020	AQ
04/20/04	VIVUS : Announces Agreement with IEH Biopharma LLC Granting the Company a 30-Day Grace Period to Restructure its Corporate Debt	AQ
01/20/01	VIVUS to Host First Quarter Business Update and Financial Results Conference Call on Wednesday, May 6, 2020	GL
01/20/01	VIVUS Announces Agreement with IEH Biopharma LLC Granting the Company a 30-Day Grace Period to Restructure its Corporate Debt	GL
01/20/01	VIVUS INC : Entry into a Material Definitive Agreement, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
04/20/04	VIVUS INC : Other Events, Financial Statements and Exhibits (form 8-K)	AQ
04/20/04	VIVUS Announces Closing of $11.55 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules	GL
03/20/03	VitalTech : Partners with VIVUS Pharmaceuticals to Accelerate Launch of Telehealth and Remote Patient Monitoring Modules	PR
03/20/03	VIVUS INC : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
01/20/01	VIVUS : Announces $11.55 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules	AQ
01/20/01	VIVUS : Accelerates the Launch of Telemedicine and Remote Monitoring Modules to Facilitate Effective Patient Care during 'Social Distancing'	AQ
31/20/31	VIVUS INC : Other Events, Financial Statements and Exhibits (form 8-K)	AQ
31/20/31	VIVUS Accelerates the Launch of Telemedicine and Remote Monitoring Modules to Facilitate Effective Patient Care During “Social Distancing”	GL